plasma
cell
disord
paul
mellor
classic
term
plasma
cell
termin
differenti
b
lymphocyt
myeloma
cell
neoplast
transform
progeni
simplist
definit
plasma
cell
disord
pcd
complex
group
compris
divers
spectrum
benign
condit
cancer
known
myelomarel
disord
mrd
multipl
myeloma
mm
primogenitor
pcd
first
report
human
cancer
becom
synonym
skelet
involv
multistep
transform
model
hypothes
develop
myeloma
human
myeloma
cell
believ
deriv
somat
mutat
isotypeswitch
postgermin
center
b
cell
correspond
longliv
plasma
cell
intramedullari
plasma
cell
develop
karyotyp
instabl
form
immort
clone
clone
number
increas
premalign
bone
marrow
mrd
becom
evid
clonal
cell
evolv
morpholog
transit
concomit
cancer
myeloma
featur
develop
multipl
myeloma
eventu
extens
extramedullari
metastas
histor
diagnost
criteria
appli
human
patient
emphas
central
bone
involv
wide
adopt
diagnosi
felin
myeloma
numer
disord
plasma
cell
neoplast
nonneoplast
recogn
time
three
disord
particular
provid
illustr
histor
background
pcd
name
extramedullari
plasmacytoma
emp
monoclon
gammopathi
undetermin
signific
mgu
immunoglobulin
amyloidosi
ia
extramedullari
plasmacytoma
tumor
plasma
cell
aris
soft
tissu
involv
bone
marrow
human
consid
rare
tumor
constitut
approxim
mrd
progress
mm
small
proport
peopl
blur
diagnost
distinct
occur
among
differ
mrd
also
among
nonneoplast
preneoplast
neoplast
pcd
kyle
introduc
term
monoclon
gammopathi
undetermin
signific
mgu
observ
proport
asymptomat
human
patient
monoclon
protein
discern
neoplasia
higher
risk
go
develop
mrd
mm
macroglobulinemia
ia
establish
amyloid
fibril
primari
amyloidosi
compris
immunoglobulin
ig
light
chain
note
biopsi
patient
ia
typic
show
signific
abnorm
protein
deposit
amyloid
appear
plasma
cell
either
evid
low
densiti
within
tissu
interest
elsewher
bone
marrow
gener
histor
term
ia
perhap
often
consid
within
context
protein
conform
diseas
see
patholog
protein
deposit
diseas
less
relat
mrd
first
author
describ
case
felin
myeloma
holzworth
meier
sinc
cat
varieti
mrd
describ
form
case
studi
small
case
seri
mani
report
prism
myeloma
defin
human
howev
appear
extramedullari
involv
may
common
cat
diagnost
criteria
myeloma
review
largest
peerreview
case
seri
thu
far
describ
cat
three
larg
seri
felin
neoplasm
mrd
account
n
n
n
malign
comparison
mrd
account
tumor
dog
human
within
subset
hematolog
neoplasia
mrd
account
n
affect
cat
affect
human
report
sex
distribut
felin
mrd
femal
male
one
studi
femal
male
anoth
comparison
human
myeloma
common
male
cat
major
mrd
case
report
domest
shorthair
cat
older
cat
report
median
year
rang
year
etiolog
felin
mrd
rel
unexplor
one
studi
entir
medic
record
obtain
report
cat
specif
assess
evid
histor
concurr
chronic
antigen
stimul
two
cat
evid
chronic
inflamm
studi
entir
vaccin
histori
patient
examin
indic
associ
mrd
bone
pain
due
osteolysi
key
featur
histor
understand
mm
human
howev
contrast
may
common
featur
felin
mrd
one
felin
mrd
seri
lame
report
case
none
patient
report
lame
radiograph
evid
bone
lysi
report
lame
andor
skelet
pain
radiograph
evid
bone
lysi
describ
assess
bone
pain
pose
difficulti
cat
like
underestim
owner
clinician
extramedullari
involv
frequent
appar
time
initi
present
felin
mrd
contrast
human
extramedullari
involv
rare
present
featur
instead
usual
associ
metastat
progress
intramedullari
compart
spleen
liver
skin
commonli
affect
organ
cat
wide
rang
organ
system
either
singli
combin
multiorgan
involv
includ
bone
marrow
report
risk
hyperviscos
syndrom
hv
rise
increas
level
serum
monoclon
protein
also
increas
overal
case
felin
mrd
assess
felin
infecti
periton
fip
includ
felin
coronaviru
serolog
either
neg
lowtit
presenc
felin
leukemia
viru
examin
case
either
antigen
enzymelink
immunosorb
assay
elisa
direct
immunofluoresc
assay
singl
test
singl
case
posit
similarli
elisa
test
antibodi
felin
immunodefici
viru
carri
cat
reveal
two
case
singletest
posit
result
role
chronic
infect
establish
felin
mrd
rule
exampl
infect
suscept
mice
abelson
murin
leukemia
viru
retrovir
construct
hasten
develop
plasma
cell
neoplasia
human
mrd
patient
defin
etiolog
howev
connect
mrd
report
ioniz
radiat
petroleumrel
product
cat
mrd
may
free
clinic
sign
time
present
diagnost
investig
may
mount
result
incident
find
routin
blood
analysi
nonspecif
clinic
sign
describ
felin
myeloma
includ
lethargi
weak
reduc
appetit
vomit
diarrhea
altern
number
common
clinic
manifest
aris
may
pathogenet
summar
focal
problem
attribut
local
cellular
infiltr
plasma
cell
myeloma
cell
infiltr
lesion
mass
develop
bone
lysi
organomegali
mass
ii
focal
problem
attribut
consequ
clonal
plasma
cell
protein
product
ie
focal
light
chain
amyloid
ig
deposit
iii
system
problem
attribut
consequ
plasma
cell
protein
product
eg
renal
insuffici
reciproc
humor
immunoparesi
coagulopathi
hyperviscos
amyloidosi
ig
deposit
diseas
iv
system
problem
attribut
damag
aris
widespread
local
cellular
infiltr
myeloma
cell
eg
hypercalcemia
widespread
osteolysi
follow
clinic
featur
commonli
ascrib
myeloma
anemia
renal
dysfunct
hypercalcemia
intramedullari
involv
extramedullari
involv
hyperviscos
neurolog
sign
coagulopathi
immunosuppress
clinic
sign
nonregen
normocyt
normochrom
anemia
common
felin
mrd
larger
case
seri
pathogenesi
anemia
multifactori
includ
alter
bone
marrow
microenviron
myelophthisi
hypoerythropoietinemia
associ
initi
investig
follow
present
featur
pcd
patient
previous
state
may
display
protean
clinic
sign
rout
diagnosi
typic
achiev
follow
two
pathway
discoveri
hyperglobulemia
investig
lesion
mass
appropri
next
stage
test
serum
protein
electrophoresi
spe
see
clinic
patholog
gammopathi
regardless
whether
globulin
rise
polyor
monoclon
significantli
elev
globulin
progress
elev
time
demonstr
patient
clinic
histori
examin
review
effort
local
identifi
possibl
lesion
associ
hyperglobulinemia
indic
spe
indic
monoclon
protein
biopsi
soft
tissu
lesion
particularli
liver
spleen
skin
mass
skelet
lesion
andor
bone
marrow
sampl
includ
aspir
core
trephin
warrant
lesion
may
macroscop
visibl
imag
discoveri
organomegali
skelet
lesion
usual
lesion
interest
sampl
although
individu
clinic
judgment
use
surrog
sampl
site
associ
lower
risk
morbid
necessari
desir
diagnosi
initi
tent
cytolog
histopatholog
report
plasma
cell
lesion
andor
amyloid
case
former
essenti
demonstr
presenc
absenc
plasma
cell
clonal
tissu
interest
see
achiev
patholog
diagnosi
myelomarel
disord
case
amyloid
like
lesion
amyloid
type
confirm
diagnosi
ia
pcd
suspect
patient
outstand
clinic
issu
reevalu
exampl
hyperviscos
suspect
hyperviscos
syndrom
clinic
diagnosi
base
demonstr
elev
serum
monoclon
protein
conjunct
appropri
clinic
sign
particular
ophthalm
sign
viscos
measur
serum
plasma
whole
blood
typic
use
diagnosi
instead
use
monitor
patient
undergo
plasmapheresi
event
suspect
hv
concurr
neurolog
sign
cardiovascular
problem
heart
murmur
associ
hypertroph
cardiomyopathi
present
water
intak
andor
urin
output
thought
abnorm
renal
function
calcium
statu
urinalysi
assess
pallor
present
anemia
character
bleed
report
coagul
assess
could
bone
pain
possibl
patient
without
imag
evid
bone
lesion
confid
level
lesion
solitari
evid
multifoc
certain
type
monoclon
protein
eg
commonli
igm
also
iga
subclass
igg
hyperviscos
syndrom
caus
neurolog
sign
visual
chang
includ
blind
due
retin
hemorrhag
detach
renal
failur
hypertroph
cardiomyopathi
cardiac
failur
thromboembol
diseas
bleed
diathesi
central
neurolog
sign
report
cat
mrd
wide
rang
neurolog
sign
report
includ
behavior
chang
seizur
tremor
ataxia
paresi
pathogenesi
neurolog
sign
attribut
tumor
mass
effect
intracrani
spinal
cord
nerv
compress
hyperviscos
hypercalcemia
mening
involv
peripher
neuropathi
also
report
potenti
caus
neurolog
sign
serum
monoclon
protein
interfer
coagul
cascad
endotheli
platelet
function
hyperviscos
reduc
capillari
flow
exacerb
clot
problem
bleed
thrombot
problem
observ
bleed
disord
includ
epistaxi
oral
bleed
melena
hyphema
retin
hemorrhag
report
felin
mrd
immunosuppress
numer
mechan
reduc
cellular
humor
immun
describ
human
myeloma
patient
includ
numer
function
abnorm
dendrit
cell
cell
natur
killer
cell
reciproc
humor
immunoparesi
reduc
level
polyclon
ig
result
high
serum
monoclon
protein
level
predispos
patient
infect
encapsul
bacteria
particular
organ
associ
pneumonia
mani
myeloma
therapi
worsen
immunosuppress
infect
princip
caus
death
lead
caus
morbid
human
myeloma
patient
immunosuppress
infect
like
underrecogn
felin
patient
sever
fatal
infect
report
individu
felin
mrd
case
eg
respiratori
tract
infect
sepsi
sever
fungal
infect
pyothorax
divers
sign
report
associ
felin
mrd
includ
constip
case
small
intestin
plasma
cell
mass
irid
color
chang
intraocular
involv
pleural
effus
facial
edema
lymphadenomegali
glaucoma
irid
involv
chronic
nasal
discharg
sinonas
involv
oncolog
involv
addit
imag
studi
indic
descript
test
may
consid
felin
mrd
given
hyperglobulinemia
gammopathi
broadli
divid
polyclon
monoclon
protein
increas
polyclon
globulin
increas
associ
reactiv
inflammatori
plasma
cell
disord
patient
gener
consid
mrd
monoclon
protein
also
known
mprotein
myeloma
protein
subset
paraprotein
ig
typic
normal
structur
charg
present
excess
quantiti
hallmark
mrd
standard
highresolut
agaros
gel
spe
report
identifi
monoclon
protein
human
patient
mm
howev
low
level
monoclon
protein
conceal
within
beta
gamma
region
routin
spe
trace
time
may
case
mrd
intercurr
anoth
diseas
process
induc
polyclon
gammopathi
probabl
misdiagnos
reflect
reactiv
inflammatori
plasma
cell
lesion
consid
review
key
morpholog
featur
matur
plasma
cell
also
known
termin
differenti
plasma
cell
marschalko
cell
plasmacyt
follow
intens
basophil
cytoplasm
due
high
ribonucleoprotein
content
acroplasm
pale
perinuclear
hof
focal
area
clear
repres
promin
golgi
apparatu
eccentr
nuclear
posit
cartwheel
chromatin
arrang
variat
plasma
cell
morpholog
clearli
defin
human
plasmacytoid
descriptor
nonspecif
variat
matur
plasma
cell
characterist
plasma
cell
type
appear
cell
nonb
cell
origin
lymphoplasmacytoid
cell
mix
lymphocyt
matur
plasma
cell
appear
typic
less
basophil
cytoplasm
flame
cell
andor
thesaurocyt
red
violac
color
cytoplasm
attribut
accumul
high
carbohydr
content
ig
within
endoplasm
reticulum
cisterna
mott
cell
contain
multipl
cytoplasm
russel
bodi
ig
inclus
proplasmacyt
larger
matur
plasma
cell
greater
anisocytosi
asynchron
nuclear
cytoplasm
matur
indistinct
small
nucleoli
plasmablast
larger
matur
plasma
cell
greater
anisocytosi
narrow
rim
cytoplasm
less
distinct
inappar
perinuclear
hof
high
n
c
ratio
larg
immatur
round
ovoid
eccentr
nucleu
anisokaryosi
one
promin
nucleoli
binucl
trinucl
multinucl
giant
myeloma
cell
may
also
observ
felin
mrd
literatur
mani
histopatholog
cytopatholog
report
felin
mrd
simpli
describ
neoplasia
compris
plasma
cell
report
provid
greater
detail
virtual
morpholog
descriptor
use
human
myeloma
use
cat
includ
matur
marschalkotyp
plasma
cell
plasmacytoid
lymphoplasmacytoid
flame
cell
russel
bodi
mott
cell
proplasmacyt
plasmablast
giant
multinucl
myeloma
cell
cytopatholog
histopatholog
exampl
cell
may
seen
veterinari
myeloma
websit
taken
isol
examin
singl
plasmacytoid
cell
even
group
plasma
cell
allow
cytopathologist
histopathologist
defin
cell
myeloma
cell
say
neoplast
transform
electrophoret
test
improv
eg
capillari
zone
electrophoresi
furthermor
combin
test
use
increas
diagnost
accuraci
pcd
serum
protein
electrophoresi
detect
monoclon
level
low
mgl
immunofix
low
mgl
latest
nephelometr
immunoassay
serum
immunoglobulin
free
light
chain
sflc
capabl
detect
less
mgl
quantif
sflc
recommend
human
mrd
patient
purpos
diagnosi
prognosi
monitor
note
even
standard
electrophoresi
methodolog
detect
quantit
abnorm
alway
reliabl
identifi
monoclon
protein
differenti
exampl
restrict
oligoclon
gammopathi
therefor
immunofix
electrophoresi
use
confirmatori
gold
standard
test
presenc
monoclon
protein
distinguish
heavi
light
chain
type
urin
collect
urin
protein
electrophoresi
protein
quantif
immunofix
addit
test
frequent
use
investig
monoclon
gammopathi
human
although
case
hyperglobulinemia
commonli
assign
either
polyor
monoclon
gammopathi
univers
dichotom
human
patient
biclon
triclon
gammopathi
describ
confirm
lymphoprolif
neoplasm
undetermin
signific
other
nonhematolog
diseas
cat
case
hyperglobulinemia
typic
assess
standard
agaros
gel
electrophoresi
use
capillari
zone
electrophoresi
immunoelectrophoresi
immunofix
recent
describ
felin
mrd
case
felin
hyperglobulinemia
polyclon
gammopathi
underli
caus
polyclon
gammopathi
divers
rang
disord
reactiv
inflammatori
plasma
cell
compon
monoclon
gammopathi
cat
commonli
associ
mrd
andor
lymphoma
monoclon
gammopathi
report
rare
case
fip
lymphocyticplasmacyt
stomat
anaplasmosi
howev
stringenc
diagnosi
latter
report
rel
uncertain
describ
base
histopatholog
hematopatholog
confirmatori
test
furthermor
possibl
ascertain
bia
coincident
associ
note
biclon
paraproteinemia
report
felin
mrd
evolv
complex
precis
analysi
interpret
gammopathi
seen
human
patient
avail
cat
report
felin
literatur
monoclon
biclon
gammopathi
associ
mrd
may
incorrect
absenc
immunofix
electrophoresi
confirm
clonal
mrd
within
tissu
interest
furthermor
four
case
report
felin
literatur
mrd
basi
routin
histopatholog
demonstr
tissu
clonal
instead
polyclon
gammopathi
progress
morpholog
chang
within
plasma
cell
ultim
develop
plasmablast
featur
clearli
correl
accumul
cytogenet
aberr
progress
clinic
diseas
yet
morpholog
chang
take
place
uniformli
divers
popul
plasma
cell
morpholog
may
seen
within
singl
biopsi
therefor
provision
diagnosi
mrd
achiev
synthesi
multipl
observ
includ
lesion
perilesion
tissu
cellular
chang
densiti
plasma
cell
well
plasma
cell
morpholog
featur
rel
proport
cell
soft
tissu
presenc
massrel
chang
allow
greater
confid
provision
diagnosi
within
bone
marrow
although
near
complet
effac
marrow
caviti
plasma
cell
occasion
observ
common
see
vari
degre
plasma
cell
densiti
cut
greater
infiltr
requir
diagnosi
demonstr
monoclon
tissu
interest
remain
gold
standard
patholog
compon
diagnosi
hematopoiet
neoplasia
eg
patient
concurr
mgu
unrel
round
cell
tumor
misinterpret
mrd
demonstr
polyclon
within
tissu
interest
impli
reactiv
inflammatori
plasma
cell
popul
clonal
may
investig
via
number
techniqu
immunohistochemistri
immunocytochemistri
allow
surrog
demonstr
clonal
express
singl
ig
light
chain
reveal
common
techniqu
veterinari
medicin
altern
techniqu
includ
flow
cytometri
molecular
biolog
test
polymeras
chain
reaction
southern
blot
array
cytogenet
epigenet
test
practic
term
confirm
presenc
ia
also
use
surrog
marker
clonal
awar
rare
patient
may
discord
result
publish
felin
mrd
seri
arguabl
insuffici
stringent
inclus
criteria
individu
patient
diagnos
mrd
basi
histopatholog
alon
serum
urin
protein
electrophoresi
carri
assess
clonal
practic
veterinari
medicin
often
pragmat
clinic
supposit
mrd
routin
hematoxylin
eosin
h
e
stain
patholog
cytopatholog
provid
morpholog
diagnosi
consist
mrd
combin
indirect
indic
clonal
ie
detect
monoclon
protein
serum
urin
howev
import
clonal
confirm
tissu
interest
case
felin
mrd
report
one
studi
histopatholog
sampl
origin
diagnosi
mrd
made
divers
boardcertifi
pathologist
variou
institut
laboratori
subject
review
independ
panel
boardcertifi
pathologist
examin
h
e
stain
section
along
addit
histochem
immunohistochem
stain
section
n
case
eventu
shown
clonal
mrd
light
chain
restrict
exclud
felin
case
b
cell
origin
despit
plasmacytoid
appear
instead
prove
histiocyt
neoplasm
mast
cell
tumor
cellular
morpholog
link
function
nonb
lymphoid
cell
high
demand
protein
product
eg
ig
may
plasmacytoid
appear
exampl
includ
plasmacytoid
dendrit
cell
histiocyt
salivari
gland
duct
lumin
cell
myoepitheli
cell
human
patient
intern
accept
standard
morpholog
categor
mrd
key
featur
report
system
divis
welldifferenti
intermediategrad
poorli
differenti
tumor
depend
proport
cell
type
matur
plasma
cell
poorli
differenti
plasmablast
cell
tumor
grade
prognost
signific
gener
good
agreement
cytolog
histolog
categor
tumor
two
case
seri
clonal
confirm
mrd
present
tumor
morpholog
classif
system
cat
largest
case
seri
felin
mrd
thu
far
tumor
classifi
welldifferenti
less
plasmablast
remaind
matur
myeloma
cell
proplasmacyt
lymphocyt
intermediategrad
plasmablast
poorli
differenti
greater
plasmablast
correl
morpholog
surviv
prove
statist
signific
cat
welldifferenti
tumor
increas
median
surviv
time
rel
poorli
differenti
tumor
versu
day
figur
amyloidosi
subset
protein
conform
diseas
share
common
pathophysiolog
mechan
proteotox
occur
direct
cellular
toxic
effect
amyloid
precursor
well
damag
organ
structur
function
via
massiv
deposit
amyloid
fibril
extracellular
space
biopsi
must
show
amyloid
deposit
confirm
congor
stain
applegreen
birefring
polar
light
microscopi
amyloid
must
type
histor
achiev
histochem
assess
immunohistochemistri
although
recent
supplant
laser
microdissect
mass
spectrometri
lmdm
type
allow
precis
categor
amyloid
numer
amyloidogen
protein
discov
singl
group
relev
mrdthe
ia
histor
ia
diseas
larg
consid
separ
mrd
even
recent
time
ia
describ
author
nonprolif
nonneoplast
pcd
howev
current
work
confirm
share
aspect
pathogenesi
term
relev
highlight
later
reactiv
plasmacytosi
plethora
inflammatori
diseas
contain
lesser
greater
number
polyclon
plasma
plasmacytoid
cell
particularli
felin
speci
plasma
cell
pododermat
nasal
plasma
cell
dermat
plasma
cell
stomatitispharyng
inflammatori
plasma
cell
disord
cat
cat
present
combin
aforement
disord
accompani
polyclon
gammopathi
report
case
across
three
disord
infecti
etiolog
demonstr
immunemedi
pathogenesi
suspect
two
cat
possibl
connect
mrd
constru
singl
report
felin
stomat
monoclon
protein
demonstr
serum
urin
howev
valid
report
question
proof
disproof
clonal
within
tissu
biopsi
exclus
intercurr
mrd
altern
locat
second
case
cat
pododermat
report
subsequ
develop
system
amyloidosi
type
amyloidosi
confirm
ig
origin
exclus
intercurr
mrd
altern
locat
plasma
cell
granuloma
commonli
known
inflammatori
pseudotumor
cat
inflammatori
myofibroblast
tumor
contain
polyclon
plasma
cell
clinic
patholog
readili
distinguish
pcd
mrd
monoclon
gammoptahi
undetermin
signific
describ
find
serum
monoclon
protein
without
clinic
investig
evid
myeloma
see
tabl
diagnost
criteria
proport
healthi
peopl
mgu
increas
age
longterm
followup
studi
mgu
human
approxim
patient
evolv
classic
mm
patient
describ
benign
monoclon
gammopathi
point
death
death
due
nonmyelomarel
caus
howev
despit
fact
mgu
patient
within
lifespan
develop
overt
symptom
myeloma
expect
clonal
plasma
cell
disord
cytogenet
studi
alon
plasma
cell
clone
demonstr
human
patient
mgu
human
myeloma
patient
believ
progress
mgu
smolder
myeloma
asymptomat
myeloma
myeloma
see
tabl
diagnost
criteria
monoclon
gammopathi
undetermin
signific
first
report
cat
although
stringenc
underli
cytogenet
aberr
well
outcom
subset
human
patient
suggest
ia
consid
lowprolif
neoplast
mrd
felin
pcd
amyloidosi
confirm
light
microscopi
report
confirm
amyloid
type
ig
inconsist
system
local
form
ia
suspect
cat
precis
amyloid
type
cat
includ
immunohistochemistri
lmd
ms
conduct
assist
human
medic
laboratori
paul
mellor
unpublish
observ
monoclon
immunoglobulin
deposit
diseas
midd
rare
human
character
deposit
monoclon
ig
molecul
basement
membran
contrast
amyloidosi
deposit
nonfibrillar
congor
neg
noncongophil
ig
deposit
describ
cat
midd
yet
describ
felin
literatur
exist
felin
literatur
outlin
divers
pcd
present
plasma
cell
disord
describ
sometim
confus
terminolog
diagnost
criteria
smolder
myeloma
indol
myeloma
asymptomat
myeloma
formal
describ
felin
literatur
howev
least
one
report
felin
case
would
consist
descript
variabl
criteria
use
histor
typic
exampleat
least
two
follow
criteria
monoclon
gammopathi
inadequ
stringent
diagnost
criteria
felin
literatur
poem
polyneuropathi
organomegali
endocrinopathi
monoclon
gammopathi
skin
chang
spe
serum
protein
electrophoresi
cathet
placement
surgeri
patholog
fractur
howev
primari
true
emp
monoclon
plasma
cell
neoplasm
aris
de
novo
soft
tissu
without
evid
concurr
bone
marrow
involv
see
tabl
evid
extramedullari
tissu
may
common
primari
site
myeloma
cell
develop
intramedullari
compart
cat
patholog
report
cutan
mass
felin
mrd
rel
accompani
comprehens
clinic
investig
allow
diagnosi
cutan
extramedullari
plasmacytoma
cempse
tabl
felin
cemp
appar
solitari
mass
associ
system
sign
hyperglobulinemia
surgic
excis
result
prolong
surviv
similar
biolog
behavior
typic
shown
speci
cemp
usual
nonsecretori
benign
cours
surgic
excis
cur
rare
cemp
show
malign
cours
progress
myeloma
either
human
dog
contrast
number
felin
mrd
report
exist
cat
cutan
plasma
cell
neoplasm
exhibit
system
sign
demonstr
monoclon
protein
affect
multiorgan
plasma
cell
infiltr
experienc
rapid
tumor
develop
noncutan
extramedullari
plasmacytoma
ncemp
appear
common
cat
compris
mrd
case
bone
marrow
abdomin
organ
sampl
carri
one
seri
occasion
felin
ncemp
report
describ
isol
tumor
show
local
sign
without
evid
system
involv
hyperglobulinemia
eg
within
uveal
tract
sinonas
caviti
howev
major
felin
ncemp
felin
case
sign
system
ill
accompani
monoclon
protein
later
metastat
multisit
develop
typic
liver
andor
spleen
infiltr
locat
includ
kidney
gastrointestin
tract
lymph
node
stomach
epidura
orbit
retroperiton
space
largest
clinic
seri
confirm
felin
mrd
hypothesi
cat
mrd
commonli
present
extramedullari
involv
contrast
human
patient
mrd
demonstr
versu
respect
p
singl
cat
patholog
diagnosi
uveal
mandibular
lymph
node
plasma
cell
neoplasia
along
immunohistochem
confirm
cellular
cytoplasm
igg
express
monoclon
gammopathi
assess
serum
protein
electrophoresi
alon
serum
urin
studi
monoclon
protein
carri
stringent
diagnost
criteria
necessari
tent
diagnosi
nonsecretori
myeloma
see
tabl
less
human
patient
diagnos
mrd
describ
nonsecretori
myeloma
immunohistochem
studi
demonstr
presenc
cytoplasm
monoclon
protein
within
plasma
cell
patient
eg
ig
synthesi
intact
exclus
mrd
known
detail
clinic
investig
lack
earlier
paper
felin
mgu
report
cat
monoclon
gammopathi
evid
clinic
sign
abnorm
hematolog
biochem
radiograph
evid
lytic
lesion
ultrasonograph
evid
lesion
light
chain
proteinuria
less
marrow
plasma
cell
content
cat
develop
myeloma
year
age
detail
progress
document
report
expect
cat
evolv
mgu
though
smolder
myeloma
ultim
myeloma
classic
case
mm
describ
cat
mark
bone
marrow
plasma
cell
infiltr
radiograph
evid
bone
lysi
monoclon
protein
detect
serum
andor
urin
diagnost
criteria
given
tabl
howev
confus
earlier
literatur
regard
diagnost
criteria
mm
cat
exampl
cat
report
mm
despit
patholog
evid
absenc
bone
marrow
infiltr
instead
extramedullari
involv
gener
across
felin
literatur
given
histor
diagnost
criteria
like
tendenc
report
bia
toward
mm
case
involv
radiograph
bone
lesion
examin
literatur
prior
case
type
mrd
describ
provid
clinic
detail
investig
mainli
form
case
report
small
case
seri
case
explicitli
describ
mm
radiograph
evid
bone
lesionsa
notabl
low
proport
comparison
humansin
mm
case
radiograph
detect
osteolysi
two
larger
clinic
case
seri
mm
publish
one
seri
singl
institut
mm
case
radiograph
evid
bone
lesion
anoth
seri
singl
veterinari
practic
orthoped
bia
proport
howev
multidepartment
multicent
clinic
case
seri
author
propos
felin
mrd
case
infrequ
present
radiograph
bone
lesion
addit
statist
support
hypothesi
conclus
drawn
limit
retrospect
natur
studi
failur
obtain
complet
skelet
survey
radiograph
case
imperfect
comparison
made
howev
given
preexist
literatur
author
find
probabl
fewer
felin
mrd
case
classic
radiograph
detect
osteolysi
compar
human
patient
soft
tissu
involv
aris
metastat
extens
intramedullari
myeloma
via
hematogen
rout
direct
extens
skelet
diseas
aris
focal
marrow
lesion
broach
cortic
bone
adjac
soft
tissu
infiltr
infiltr
traumat
area
includ
site
subcutan
inject
intraven
sever
sepsi
occasion
result
transient
elev
circul
plasma
cell
therefor
demonstr
monoclon
requir
per
mrd
eg
flow
cytometri
immunocytochemistri
cell
block
prepar
immunohistochemistri
molecular
techniqu
classifi
either
primari
pcl
present
de
novo
patient
previou
histori
mrd
secondari
observ
leukem
transform
preexist
progress
mrd
primari
pcl
distinct
clinicpatholog
entiti
differ
cytogenet
molecular
find
plasma
cell
leukemia
report
three
cat
two
case
report
provid
good
clinic
descript
secondari
pcl
earlier
section
seen
pcd
form
complex
set
disord
inde
human
addit
disord
involv
plasma
cell
patholog
gammopathi
yet
describ
felin
literatur
past
two
decad
move
classifi
human
patient
new
categori
symptomat
multipl
myeloma
new
diagnosi
accommod
patient
either
intramedullari
extramedullari
diseas
see
tabl
symptomat
multipl
myeloma
also
accord
signific
whether
patient
display
sign
myelomarel
end
organ
damag
may
valu
recategor
mrd
veterinari
medicin
employ
system
potenti
facilit
greater
consist
diagnost
investig
classif
propos
system
retain
central
role
patholog
diagnosi
alter
patientcentr
focu
explicitli
incorpor
broader
rang
myelomarel
clinic
problem
system
incorpor
lymphoprolif
disord
mrd
proteinrel
function
disord
eg
lymphoma
patient
produc
monoclon
protein
patient
ia
midd
ultim
system
combin
diagnosi
risk
stratif
system
last
point
particular
assist
indistinct
boundari
tradit
mrd
diagnost
categori
may
observ
patient
speci
patient
may
asymptomat
low
cellular
prolifer
benign
monoclon
gammopathi
time
death
clinic
affect
low
cellular
prolifer
immunoglobulin
amyloidosi
clinic
affect
high
cellular
prolifer
multipl
myeloma
furthermor
clonal
plasma
cell
show
wide
vari
biolog
behavior
within
patient
cours
lifetim
propos
new
system
plasma
cell
disord
may
subcategor
myelomarel
disord
typic
combin
cytopatholog
histopatholog
ii
demonstr
clonal
tissu
interest
iii
evid
clinic
problem
attribut
mrd
therefor
distinguish
featur
mrd
judgment
regard
transit
neoplast
behavior
tabl
human
true
nonsecretori
myeloma
patient
detect
monoclon
protein
serum
urin
aforement
method
includ
sflc
solitari
plasmacytoma
bone
spb
patient
present
singl
lesion
monoclon
plasma
cell
bone
evid
myeloma
cell
elsewher
typic
patient
present
local
sign
eg
bone
pain
associ
lesion
although
patient
painless
boni
deform
neurolog
sign
associ
compress
lesion
discov
incident
find
radiograph
survey
purpos
solitari
plasmacytoma
bone
rare
mrd
clinic
evolut
spb
mm
recogn
although
key
featur
sbp
patient
slow
natur
time
cours
diseas
progress
diagnost
test
methodolog
advanc
diagnost
criteria
spb
chang
exampl
mani
spb
patient
discov
monoclon
protein
advent
sensit
techniqu
assess
patient
thought
affect
spb
instead
reclassifi
mm
magnet
reson
imag
mri
discoveri
addit
bone
lesion
appar
standard
skelet
radiograph
survey
current
diagnost
criteria
sbp
given
tabl
two
felin
case
sbp
report
cat
present
singl
spinal
lesion
caus
neurolog
sign
treat
prolong
remiss
sever
year
achiev
radiotherapi
one
case
chemotherapi
human
macroglobulinemia
common
subset
compar
rare
igm
macroglobulinemia
rare
report
cat
felin
case
provid
greater
investig
detail
includ
postmortem
find
found
igmsecret
lymphoplasmacytoid
cell
liver
evid
bone
marrow
infiltr
patient
present
either
risk
factor
develop
actual
clinic
sign
mrd
dysfunct
eg
gammopathi
amyloidosi
lack
typic
plasma
cell
plasmacytoid
cell
characterist
assess
routin
cytopatholog
histopatholog
immunocytoor
immunohistochemistri
flow
cytometri
etc
instead
classifi
lymphoma
sever
felin
case
describ
literatur
igsecret
lymphoma
limit
patholog
descript
rang
lymphoid
cell
lymphoplasmacyt
cell
plasma
cell
leukemia
pcl
rare
aggress
mrd
character
presenc
circul
plasma
cell
see
tabl
note
nonneoplast
condit
tabl
area
patholog
amyloid
must
demonstr
immunoglobulin
origin
midddeposit
must
shown
amyloid
protein
column
usual
neg
usual
posit
refer
absenc
presenc
monoclon
spike
standard
protein
electrophoresi
serum
urin
low
posit
refer
presenc
small
monoclon
spike
detect
either
examin
origin
densitomet
trace
standard
protein
electrophoresi
sensit
assess
techniqu
see
text
detail
total
serum
globulin
level
slightli
elev
within
normal
limit
problem
column
refer
text
descript
key
mrd
attribut
problem
aris
organ
damag
tissu
impair
system
multifoc
local
vital
organ
failur
eg
kidney
liver
may
chronic
acuteonchron
present
vital
organ
failur
alway
includ
simpl
viscer
organ
capsular
compromis
lead
capsular
ruptur
hemorrhag
eg
infiltr
spleen
system
problem
princip
attribut
myeloma
ia
includ
limit
renal
failur
hv
coagulopathi
anemia
hypercalcemia
multifoc
organ
problem
includ
multipl
osteolyt
lesion
multifoc
soft
tissu
organ
disrupt
impair
b
key
local
problem
solitari
osteolysi
solitari
organ
disrupt
focal
compress
sign
result
organ
damag
impair
c
key
problem
patient
either
appar
asymptomat
limit
clinic
sign
includ
key
local
system
mrd
attribut
problem
earlier
final
consider
overal
rate
progress
risk
base
earlier
natur
behavior
mrd
allow
tent
global
categor
risk
progress
morbid
see
tabl
veterinari
medicin
crude
stratif
estim
system
prove
adapt
addit
diagnost
stratif
criteria
time
eg
apppo
inclus
allow
consider
independ
prognost
featur
serum
albumin
microglobulin
cytogenet
etc
use
human
case
exampl
diagnost
approach
given
tabl
stratifi
patient
wayaccord
evolutionari
stage
diseasethi
new
system
prove
use
aid
clinic
decis
make
respect
therapi
see
tabl
treatment
polyclon
pcd
report
pauciti
systemat
data
regard
treatment
felin
mrd
treatment
suspect
confirm
mrd
dictat
risk
stratif
suggest
earlier
earlier
section
concern
diagnost
clear
appar
solitari
lesion
examin
skeptic
sound
knowledg
divers
diagnost
present
avail
mrd
plan
sensibl
suffici
investig
test
gener
mani
solitari
lesion
control
local
therapi
exceptionsseen
section
tabl
howev
owner
inform
gener
remain
level
risk
progress
diseas
follow
local
therapi
solitari
mrd
lesion
case
rate
progress
risk
slow
see
tabl
local
amyloidosi
excision
biopsi
indic
result
longterm
remiss
cure
case
rate
progress
risk
moder
see
tabl
solitari
emp
surgic
excis
may
consid
purpos
diagnost
confirm
therapi
appropri
statist
signific
surviv
result
accompani
local
system
clinic
relev
problem
tent
diagnosi
suspect
mrd
achiev
absenc
cellular
evid
plasma
cell
infiltr
ia
confid
demonstr
serum
andor
urin
monoclon
protein
prefer
immunofix
altern
diagnosi
monoclon
protein
evid
suspect
mrd
preneoplast
categor
proport
patient
exampl
includ
mgu
smolder
myeloma
event
patient
death
due
unrel
caus
condit
may
never
progress
display
neoplast
behavior
term
evid
patholog
damag
clinic
relev
problem
attribut
mrd
nevertheless
clonal
disord
rational
ongo
monitor
patient
conting
upon
known
risk
develop
overt
neoplasia
summari
propos
new
system
categor
patient
accord
whether
diseas
appar
solitari
multifoc
examin
patholog
grade
describ
diseas
effect
monoclon
protein
product
andor
deposit
well
key
clinic
relev
problem
seen
patient
assess
may
summar
mnemon
appp
area
patholog
protein
problem
patient
stratifi
accord
rate
progress
risk
area
anatom
locat
defin
locat
affect
area
either
multifoc
lesion
singl
osteolyt
lesion
plu
separ
bone
marrow
site
associ
clinic
imag
evid
lesion
show
greater
plasma
cell
content
ideal
site
two
osteolyt
lesion
proof
plasma
cell
infiltr
least
one
lesion
combin
intramedullari
extramedullari
biopsi
confirm
lesion
two
biopsi
confirm
extramedullari
lesion
b
appar
solitari
lesion
qualif
imag
andor
investig
techniqu
use
assess
absenc
lesion
c
definit
lesion
eg
imag
evid
lesion
marrow
less
plasma
cell
content
qualif
techniqu
use
twosit
aspir
trephin
patholog
assess
cellular
patholog
appropri
assign
patholog
grade
well
differenti
b
intermedi
c
poorli
differenti
plasmablast
may
biopsi
lesion
low
plasma
cell
content
eg
local
amyloid
lesion
mgu
minim
plasma
cell
content
system
amyloidosi
protein
product
deposit
includ
monoclon
protein
serum
urin
ig
type
b
ia
c
midd
monoclon
protein
detect
qualif
techniqu
use
assess
monoclon
protein
key
mrd
attribut
problem
aris
relat
organ
damag
tissu
impair
may
compris
follow
key
system
multifoc
problem
pathogenet
mechan
diseas
may
present
use
steroid
alon
commonli
combin
chemotherapi
protocol
includ
melphalan
prednisolon
commonli
use
combin
cop
cyclophosphamid
vincristin
prednisolon
permut
includ
dexamethason
chlorambucil
lomustin
lasparaginas
across
literatur
gener
posit
respons
chemotherapi
document
howev
caution
must
employ
usag
melphalan
cat
typic
histor
regim
administr
mg
tablet
everi
four
day
equat
approxim
mg
kg
lb
cat
howev
myelosuppress
may
cumul
individu
result
sever
ill
accompani
mark
neutropenia
recompound
chemotherapeut
recommend
allow
accur
dose
qualit
descript
statist
assess
effect
treatment
surviv
publish
one
seri
felin
mrd
show
signific
surviv
benefit
cat
receiv
combin
chemotherapi
versu
cat
receiv
therapi
glucocorticoid
alon
novel
therapi
low
dose
dexamethason
alon
thalidomid
deriv
newer
gener
antimyeloma
drug
might
appropri
tri
appropri
select
cat
relaps
data
time
lack
data
treatment
confirm
case
felin
system
ia
human
therapi
direct
plasma
cell
clone
per
treatment
employ
myeloma
result
improv
outcom
patient
system
ia
myelomarel
disord
complic
includ
hypercalcemia
renal
failur
anemia
bone
lysi
bone
pain
patholog
fractur
bone
collaps
hyperviscos
syndrom
coagulopathi
thromboembol
diseas
infect
may
manag
array
adjunct
therapi
pauciti
data
felin
mrd
report
describ
use
plasmapheresi
allevi
congest
heart
failur
result
hv
three
cat
use
bisphosphon
control
hypercalcemia
bonerel
sign
describ
cat
could
appropri
select
case
effect
manag
bleed
embol
diseas
infect
describ
detail
cat
awar
facilit
treatment
slow
moder
progress
suspect
mrd
mgu
smolder
myeloma
owner
apprais
clinic
sign
myeloma
extramedullari
plasmacytoma
amyloidosi
may
develop
time
laboratori
test
total
globulin
andor
quantif
serum
andor
urin
monoclon
protein
consid
interv
frequent
suspicion
rapidli
progress
diseas
new
bone
benefit
select
cat
receiv
surgeri
demonstr
compar
cat
receiv
therapi
glucocorticoid
alon
varieti
surgic
therapi
includ
cutan
mass
excis
splenectomi
enucl
report
across
felin
literatur
gener
posit
respons
document
appropri
select
case
exampl
typic
clinic
decisionmak
process
solitari
plasmacytoma
spleen
might
suspect
basi
discov
serum
urin
monoclon
protein
along
sonograph
evid
splenic
structur
chang
cytopatholog
indic
well
differenti
plasma
cell
radiograph
evid
bone
lesion
base
complet
skelet
survey
test
could
includ
addit
splenic
aspir
immunocytochemistri
flow
cytometri
polymeras
chain
reaction
antigen
receptor
rearrang
well
imag
eg
mri
fluorodeoxyglucos
positron
emiss
tomographi
scan
concurr
bone
marrow
aspir
trephin
involv
site
identifi
splenectomi
would
follow
paradigm
follow
current
best
evid
human
patientsthat
truli
local
emp
access
site
complet
surgic
excis
howev
area
poor
surgic
access
eg
upper
respiratori
digest
tract
radiotherapi
alon
treatment
choic
solitari
viscer
organ
diffus
infiltr
safe
excis
irradi
eg
hepat
plasmacytoma
diffus
hepat
infiltr
may
treat
chemotherapi
per
myeloma
case
see
multifoc
lesion
solitari
plasmacytoma
bone
confirm
classifi
moder
rate
progress
risk
may
also
optim
treat
local
megavoltag
radiotherapi
solitari
mrd
highrisk
progress
categori
eg
emp
patholog
grade
poorli
differenti
tumorse
tabl
approach
caution
regard
local
therapi
alon
suspicion
possibl
undiagnos
lesion
andor
rapid
transit
multifoc
myeloma
risk
local
therapi
consid
respect
potenti
morbid
patient
versu
potenti
therapeut
gain
monoclon
gammopathi
undetermin
signific
exampl
assum
multifoc
suspect
mrd
risk
slow
progress
monitor
alon
appropri
extrapol
current
data
human
smolder
myeloma
monitor
although
trial
earli
stage
therapi
underway
multifoc
diseas
rate
progress
risk
high
see
tabl
system
chemotherapi
appropri
rate
progress
risk
class
high
mrd
accompani
organ
failur
chemotherapeut
option
dosag
consid
care
felin
literatur
mani
individu
report
describ
usag
wide
rang
option
therapi
outlook
regard
initi
respons
combin
chemotherapi
felin
mrd
good
one
studi
respond
reduc
clinic
sign
concomit
decreas
serum
globulin
level
return
good
qualiti
life
expect
patient
longterm
prognosi
howev
invari
grave
cat
receiv
treatment
glucocorticoid
alon
median
surviv
time
mst
less
month
statist
wors
cat
receiv
combin
chemotherapi
mst
month
subgroup
respond
chemotherapi
improv
clinic
reduc
globulinemia
median
surviv
month
lesion
viscer
organomegali
occasion
develop
absenc
rise
monoclon
protein
event
appropri
clinic
suspicion
imag
may
conduct
assess
eg
serum
biochemistri
hematopatholog
use
detect
impend
organ
failur
increas
peripher
blood
plasma
cell
content
respect
develop
secondari
leukemia
patient
secretori
mrd
undergo
combin
chemotherapi
improv
clinic
sign
often
expect
within
day
usual
week
one
studi
felin
mrd
patient
respond
chemotherapi
half
achiev
normoglobulinemia
within
time
period
